16.41
Schlusskurs vom Vortag:
$16.84
Offen:
$16.73
24-Stunden-Volumen:
134.14K
Relative Volume:
0.73
Marktkapitalisierung:
$411.46M
Einnahmen:
$148.73M
Nettoeinkommen (Verlust:
$-20.97M
KGV:
-17.84
EPS:
-0.92
Netto-Cashflow:
$-46.03M
1W Leistung:
-3.24%
1M Leistung:
-12.57%
6M Leistung:
-23.32%
1J Leistung:
-40.02%
Orthopediatrics Corp Stock (KIDS) Company Profile
Firmenname
Orthopediatrics Corp
Sektor
Branche
Telefon
574-268-6379
Adresse
2850 FRONTIER DRIVE, WARSAW, IN
Vergleichen Sie KIDS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
KIDS
Orthopediatrics Corp
|
16.41 | 422.30M | 148.73M | -20.97M | -46.03M | -0.92 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Orthopediatrics Corp Stock (KIDS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-07 | Eingeleitet | Lake Street | Buy |
| 2024-01-25 | Herabstufung | Truist | Buy → Hold |
| 2021-06-14 | Bestätigt | Needham | Buy |
| 2020-04-02 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-06-19 | Eingeleitet | Needham | Buy |
| 2019-02-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Orthopediatrics Corp Aktie (KIDS) Neueste Nachrichten
Is OrthoPediatrics Corp. (2X7) stock nearing a technical breakoutPortfolio Update Report & Precise Buy Zone Identification - newser.com
Is OrthoPediatrics Corp. stock attractive for long term wealth buildingWeekly Trade Review & Capital Protection Trading Alerts - newser.com
Real time breakdown of OrthoPediatrics Corp. stock performanceMarket Trend Review & Free Technical Confirmation Trade Alerts - newser.com
Is OrthoPediatrics Corp. stock oversold or undervaluedJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - newser.com
Will OrthoPediatrics Corp. price bounce be sustainableAnalyst Downgrade & Risk Managed Trade Strategies - newser.com
How risky is OrthoPediatrics Corp. (2X7) stock compared to peersWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Will OrthoPediatrics Corp. stock gain from government policiesWeekly Market Report & Weekly Consistent Profit Watchlists - newser.com
What consensus target says about OrthoPediatrics Corp. (2X7) stockJuly 2025 Technicals & Verified Swing Trading Watchlists - newser.com
How strong is OrthoPediatrics Corp. stock revenue growth2025 Risk Factors & Reliable Breakout Forecasts - newser.com
Will OrthoPediatrics Corp. (2X7) stock sustain uptrend momentumDay Trade & Safe Capital Preservation Plans - newser.com
Real time alert setup for OrthoPediatrics Corp. performanceChart Signals & Safe Entry Point Alerts - newser.com
What institutional flow reveals about OrthoPediatrics Corp.July 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com
Why OrthoPediatrics Corp. stock remains a top recommendationJuly 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
Using fundamentals and technicals on OrthoPediatrics Corp.Earnings Growth Report & High Accuracy Swing Trade Signals - newser.com
Why pension funds invest in OrthoPediatrics Corp. (2X7) stockEarnings Summary Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Will OrthoPediatrics Corp. continue its uptrendJuly 2025 Drop Watch & Safe Entry Point Identification - newser.com
OrthoPediatrics Corp. (NASDAQ:KIDS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Why OrthoPediatrics Corp. (2X7) stock stays resilientQuarterly Trade Review & Real-Time Volume Surge Alerts - newser.com
OrthoPediatrics Corp. stock momentum explainedDividend Hike & AI Optimized Trading Strategy Guides - newser.com
Should I buy OrthoPediatrics Corp. (2X7) stock before earnings seasonMarket Risk Report & Reliable Intraday Trade Alerts - newser.com
What MACD signals say about OrthoPediatrics Corp.July 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Is this a good reentry point in OrthoPediatrics Corp.2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Trustwave Securities Limited (508963) Hits 52 Week HighConsumer Goods Stocks & High Yield Investment Tips - earlytimes.in
OrthoPediatrics Corp (KIDS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges - Investing.com Canada
OrthoPediatrics Corp’s Mixed Earnings Call Review - MSN
OrthoPediatrics (NASDAQ:KIDS) Earns Buy Rating from BTIG Research - MarketBeat
OrthoPediatrics Corp. (NASDAQ:KIDS) Q3 2025 Earnings Call Transcript - Insider Monkey
OrthoPediatrics (KIDS): Losses Continue to Widen, Challenging Bullish Growth Narratives - Yahoo Finance
OrthoPediatrics (NASDAQ:KIDS) Issues Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
ORTHOPEDIATRICS CORP SEC 10-Q Report - TradingView
OrthoPediatrics price target lowered to $26 from $42 at Needham - TipRanks
Truist Raises Price Target on OrthoPediatrics to $19 From $18, Keeps Hold Rating - MarketScreener
Needham Cuts Price Target on OrthoPediatrics to $26 From $42, Keeps Buy Rating - MarketScreener
Finanzdaten der Orthopediatrics Corp-Aktie (KIDS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Orthopediatrics Corp-Aktie (KIDS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gerritzen Daniel J | General Counsel and Secretary |
Mar 18 '25 |
Sale |
24.86 |
5,310 |
132,007 |
110,767 |
| Bailey David R | President and CEO |
Mar 18 '25 |
Sale |
24.86 |
6,620 |
164,573 |
319,155 |
| Hite Fred | COO and CFO |
Mar 18 '25 |
Sale |
24.86 |
6,443 |
160,173 |
207,989 |
| Odle Gregory A | President of Scoliosis |
Mar 18 '25 |
Sale |
24.86 |
5,359 |
133,225 |
148,788 |
| Hauser Joseph W | Pres. Trauma & Def. Correction |
Mar 18 '25 |
Sale |
24.86 |
5,300 |
131,758 |
137,663 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):